1. Home
  2. TLSI vs TG Comparison

TLSI vs TG Comparison

Compare TLSI & TG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TriSalus Life Sciences Inc.

TLSI

TriSalus Life Sciences Inc.

SELL

Current Price

$6.83

Market Cap

244.3M

Sector

Health Care

ML Signal

SELL

Logo Tredegar Corporation

TG

Tredegar Corporation

HOLD

Current Price

$7.41

Market Cap

301.0M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLSI
TG
Founded
2010
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
244.3M
301.0M
IPO Year
N/A
1989

Fundamental Metrics

Financial Performance
Metric
TLSI
TG
Price
$6.83
$7.41
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$11.50
N/A
AVG Volume (30 Days)
239.6K
168.7K
Earning Date
11-13-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$40,207,000.00
$691,173,000.00
Revenue This Year
$55.06
N/A
Revenue Next Year
$46.04
N/A
P/E Ratio
N/A
$113.19
Revenue Growth
49.52
43.30
52 Week Low
$3.42
$6.25
52 Week High
$7.95
$9.43

Technical Indicators

Market Signals
Indicator
TLSI
TG
Relative Strength Index (RSI) 56.65 41.46
Support Level $6.80 $7.39
Resistance Level $7.95 $7.65
Average True Range (ATR) 0.46 0.22
MACD -0.10 -0.04
Stochastic Oscillator 21.48 3.54

Price Performance

Historical Comparison
TLSI
TG

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

About TG Tredegar Corporation

Tredegar Corp, through its subsidiaries, engages in the manufacture of polyethylene plastic films, polyester films, and aluminum extrusions. Polyethylene plastic films produce plastic films, elastics, and laminate materials that are used in personal care products, surface protection films, and specialty and optical lighting applications. The company operates through segments including PE films, flexible packaging films, and aluminum extrusions. Aluminum extrusions generate the majority of revenue and provide high-quality, soft-alloy, medium-strength aluminum utilized in the building and construction, automotive, consumer durables, machinery and equipment, electrical, and distribution markets. Revenue is generated from the United States, Asia, and Brazil.

Share on Social Networks: